Table 1. Patient Characteristics.

From: Underlying Disorders, Clinical Phenotypes, and Treatment Diversity among Patients with Disseminated Intravascular Coagulation

Total
(n = 337,132)
Age (years), mean (SD) 71 (17)
Male, n (%) 183,928 (55)
Charlson comorbidity index, mean (SD) 1.4 (1.9)
Planned or emergency admission, n (%)
 Planned admission 172,754 (51)
 Emergency admission 164,378 (49)
Intensive care unit admission, n (%) 89,316 (26)
High-care unit admission, n (%) 55,066 (16)
Surgery with general anesthesia, n (%) 88,523 (26)
Use of antibiotics, n (%) 314,033 (93)
Annual hospital volume (patients per year), mean (SD) 76 (52)
Underlying disorders, n (%)
 Marked bleeding type of DIC
  Leukemia 31,059 (9)
  Trauma 16,844 (5)
  Obstetric diseases 16,742 (5)
  Aortic diseases 9,721 (3)
 Organ failure type of DIC
  Sepsis 140,538 (42)
   Lung 37,847 (11)
   Abdomen 41,224 (12)
   Urinary tract 26,733 (8)
   Central nervous system 3,274 (1)
   Skin and soft tissues 4,882 (2)
   Cardiovascular system 6,429 (2)
   Other infections 38,090 (11)
  Pancreatitis 9,052 (3)
 Asymptomatic type of DIC
  Solid cancer 104,323 (31)
   Esophagus 3,749 (1)
   Stomach 17,911 (5)
   Colon 19,816 (6)
   Liver 9,578 (3)
   Bile duct/gallbladder 10,188 (3)
   Pancreas 10,707 (3)
   Lung 10,816 (3)
   Gynecological 4,874 (1)
   Urological 10,981 (3)
   Breast 2,575 (1)
   Other solid cancers 12,503 (4)
 Miscellaneous 8,853 (3)
Anticoagulants used for DIC, n (%)
 Antithrombin 85,488 (25)
 Recombinant thrombomodulin 122,224 (36)
 Serine protease inhibitors 125,344 (37)
 Heparin 102,048 (30)
Antifibrinolytics used for DIC, n (%)
 Tranexamic acid 47,408 (14)
Blood components used for DIC, n (%)
 Fresh frozen plasma 87,098 (26)
 Platelets 82,959 (25)
Organ failure score, mean (SD) 2.0 (1.0)
Major bleeding events, n (%) 33,454 (10)
Outcomes
 In-hospital mortality, n (%) 125,933 (37)
 Length of stay (days), mean (SD) 41 (83)
 Total hospitalization costs (thousands of USD), mean (SD) 25 (31)
PAGE TOP